Cargando…
Clinical, hormonal and metabolic parameters in women with PCOS with different combined oral contraceptives (containing chlormadinone acetate versus drospirenone)
INTRODUCTION: Polycystic ovary syndrome (PCOS) is a common endocrine disorder affecting 5–10% of women of reproductive age. It is characterized by chronic anovulation leading to menstrual disorders, and increased infertility. The syndrome can also manifest as hirsutism and acne. AIM OF THE STUDY: Th...
Autores principales: | Podfigurna, A., Meczekalski, B., Petraglia, F., Luisi, S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7067819/ https://www.ncbi.nlm.nih.gov/pubmed/31654312 http://dx.doi.org/10.1007/s40618-019-01133-3 |
Ejemplares similares
-
A comparison of combined oral contraceptives containing chlormadinone acetate versus drospirenone for the treatment of acne and dysmenorrhea: a randomized trial
por: Jaisamrarn, Unnop, et al.
Publicado: (2018) -
Combined oral contraceptives containing chlormadinone acetate and breast cancer: results of a case-control study.
por: Ebeling, K., et al.
Publicado: (1991) -
Ethinylestradiol/Chlormadinone Acetate: Dermatological Benefits
por: Guerra-Tapia, Aurora, et al.
Publicado: (2012) -
Ethinylestradiol/Chlormadinone Acetate for Use in Dermatological Disorders
por: Vázquez, Mercedes Gómez, et al.
Publicado: (2012) -
Drospirenone-containing oral contraceptives and venous thromboembolism: an analysis of the FAERS database
por: Madigan, David, et al.
Publicado: (2018)